Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.07 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |